Qianjin Pharmaceutical announced that Qianjin Xiangjiang Pharmaceutical, a subsidiary of the company, has received a “Drug Registration Certificate” for lurasidone hydrochloride tablets approved and issued by the State Drug Administration. This drug is used to treat schizophrenia. Domestic companies that have obtained registration certificates for this drug include Jiangsu Haisen Pharmaceutical Group Co., Ltd., Zhengda Tianqing Pharmaceutical Group Co., Ltd., and Zhejiang Haizheng Pharmaceutical Co., Ltd. Qianjin Xiangjiang Pharmaceutical has invested a total of 6.3294 million yuan in R&D of lurasidone hydrochloride tablets. Lurasidone hydrochloride tablets have obtained a drug registration certificate, which is considered to have passed the consistency evaluation, further enriching the company's product pipeline and contributing to the company's sustainable development. However, the production and sale of pharmaceuticals is easily affected by factors such as national policies and changes in the market environment, and there is great uncertainty.

Qianjin Pharmaceutical announced that Qianjin Xiangjiang Pharmaceutical, a subsidiary of the company, has received a “Drug Registration Certificate” for lurasidone hydrochloride tablets approved and issued by the State Drug Administration. This drug is used to treat schizophrenia. Domestic companies that have obtained registration certificates for this drug include Jiangsu Haisen Pharmaceutical Group Co., Ltd., Zhengda Tianqing Pharmaceutical Group Co., Ltd., and Zhejiang Haizheng Pharmaceutical Co., Ltd. Qianjin Xiangjiang Pharmaceutical has invested a total of 6.3294 million yuan in R&D of lurasidone hydrochloride tablets. Lurasidone hydrochloride tablets have obtained a drug registration certificate, which is considered to have passed the consistency evaluation, further enriching the company's product pipeline and contributing to the company's sustainable development. However, the production and sale of pharmaceuticals is easily affected by factors such as national policies and changes in the market environment, and there is great uncertainty.